| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d037bc74e34c7d73dd883f208aef0518 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S930-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S930-19 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K9-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P1-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07G11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K20-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-00 |
| filingDate |
1984-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1987-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_add335289b430c4640fba2b5543d2992
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_777470b93755dcfd66dc9dddd4b708db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41be2603716b9d8837dfe2cfc09a19d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b30917410d652cc7cb610db9dc5b792
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6637691721c423e2d56fa50ac65dbaf1 |
| publicationDate |
1987-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4645827-A |
| titleOfInvention |
Glycopeptide antibiotic L 17054 |
| abstract |
The present invention is directed to the essentially pure preparation of an antibiotic substance arbitrarily designated antibiotic L 17054. This antibiotic substance is obtained from the known antibiotic substance named teicoplanin (formerly teichomycin) by chemical treatment. The new compound and the pharmaceutically acceptable salts possess antimicrobial activity. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5198418-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5594102-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4845194-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4699969-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4868171-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4698418-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5500410-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5132286-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5521155-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5185320-A |
| priorityDate |
1983-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |